Clinical Blog
Published: June 01, 2023

Leveraging Claims Data to Personalize Treatment Plans: Insights From ATS 2023 (Part Two)

Analyzing national administrative claims data can provide insights into patient behaviors and outcomes, which clinical teams can leverage to develop more personalized treatment plans and improve outcomes among high-risk patients.

Propeller Health and ResMed presented several abstracts at the ATS 2023 International Conference in Washington D.C. on May 19-24, many of which used asthma- and COPD-related administrative claims data to better understand trends in healthcare resource use as well as predictors of adherence and exacerbations among COPD and asthma patients. Read brief summaries of each abstract below or click the links to view them online.

Characteristics, healthcare resource use, and costs among high-risk patients with COPD in the United States

Summary: COPD exacerbations contribute to poor clinical outcomes, higher healthcare resource use (HCRU), and reduced quality of life for patients. Examining data from a national  administrative claims dataset, researchers described the demographic and clinical characteristics, HCRU, and healthcare costs among patients with COPD who may be considered high-risk. The analysis found that COPD-related hospitalization costs for high-risk patients were more than six times higher than non-high-risk patients. High-risk patients were also more likely to:

  • Be female and reside in the West or South regions of the U.S.
  • Have one or more comorbid condition
  • Use maintenance and rescue medications and oxygen therapy
  • Have ongoing acute care visits

The analysis provides important insights into characteristics that can help identify high-cost, high-resource patients in claims data who are at an increased risk for poor clinical outcomes.

View this abstract online.

Predictors of adherence to asthma controller medication among pediatric, adolescent, and adult patients in the United States

Summary: Research continuously demonstrates that patients with persistent asthma tend to maintain poor medication adherence. Researchers used national administrative claims data to conduct a real-world analysis of the predictors of controller medication adherence among patients with asthma. Non-adherence at baseline was the strongest negative predictor of future adherence among all age groups. Results also showed that being covered by Medicaid — versus commercial insurance — reduced the odds of controller adherence, while older age and having comorbid conditions increased the odds of adherence, though the association between specific comorbidities and adherence varied between age groups. These results suggest predictors of adherence differ by age, and care management approaches should consider patient age as well as other clinical and contextual factors.

View this abstract online.

Predictors of exacerbations among pediatric, adolescent, and adult patients with asthma in the United States

Summary: Exacerbations are a key driver of healthcare utilization and costs in asthma care. Using administrative claims data, researchers examined the predictors of exacerbations among a large, diverse sample of U.S. patients with asthma. While exacerbations occurred among all patients, they were more frequent in patients with exacerbations in the prior 12 months, Medicaid coverage, asthma-related or other respiratory conditions, and severe asthma. While history of exacerbation and asthma-related comorbidities were predictors across all age groups, a history of COPD and hypertension increased exacerbation odds among adults. Such insights suggest that asthma management approaches may further consider the impact of patient demographics and clinical profiles.

View this abstract online.

For any questions about Propeller’s peer-reviewed clinical research, please reach out to

Explore more insights from ATS 2023

Improving Clinical Outcomes Through Data Capturing and Analysis: Insights From ATS 2023 (Part One)

Advancing Equity for Respiratory Patients Through Public Health Research: Insights From ATS 2023 (Part Three)

You Might Also Like

To Boost ROI, Life Sciences Needs To Deliver What HCPs Want: Digital Companions
Today’s evolving healthcare landscape is placing increasing emphasis on whole-person care. The shift has led healthcare professionals (HCPs) to seek digital solutions that support them in creating personalized and engaging care journeys for their patients. Therefore, if life sciences wants to drive financial returns now and stay ahead in today’s competitive healthcare market, they must […]
Life Sciences Is Using Digital Companions To Create Patient-Centric Drug Experiences — And Boosting ROI in the Process
The future of healthcare revolves around creating a patient-centric ecosystem. In today’s landscape, 81% of patients report being unsatisfied with their healthcare experience.1 One of the key drivers of their dissatisfaction? Lack of patient involvement: As many as 90% of patients want shared decision-making with their physician.2 Digital companions — beyond-the-pill digital solutions that deliver […]
The Critical Prescription for Success: 4 Direct Returns Life Sciences Can Realize From a Digital Companion
Digital health’s critical role in transforming healthcare and drug delivery is not a vision for a distant future — it’s the present reality. In the past three years, the top five life sciences companies have announced more than 50 investments in digital health technology companies and partnerships.1 Life sciences is transforming traditional products into data-rich, […]